Targeting Therapy-Resistant Cancer with Radiotheranostics: Preclinical Insights from ALDH1A1- Directed Development

Name: Targeting Therapy-Resistant Cancer with Radiotheranostics: Preclinical Insights from ALDH1A1- Directed Development
Start: 2026-12-03T11:00
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 3 December 2026 · 11:00

Targeting Therapy-Resistant Cancer with Radiotheranostics: Preclinical Insights from ALDH1A1- Directed Development was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 3 December 2026 in London, with 1 speaker on record.

Speakers

Muhammet Tanc — Speaker CEO, Nuclide Therapeutics